View in EDS HTML Full Text PDF Full Text

STING‐ATF3/type I interferon crosstalk: A potential target to improve anti‐tumour immunity in chemotherapy‐treated urothelial carcinoma.

Saved in:

Bibliographic Details
Title:	STING‐ATF3/type I interferon crosstalk: A potential target to improve anti‐tumour immunity in chemotherapy‐treated urothelial carcinoma.
Authors:	Fauvre, Alexandra¹ (AUTHOR), Machu, Margot¹ (AUTHOR), Merienne, Audrey² (AUTHOR), Vie, Nadia¹ (AUTHOR), Bessede, Thomas¹ (AUTHOR), Robin, Mathilde¹ (AUTHOR), Garambois, Veronique¹ (AUTHOR), Taffoni, Clara³ (AUTHOR), Laguette, Nadine³ (AUTHOR), Gervois‐Segain, Nadine² (AUTHOR), Jarry, Anne² (AUTHOR), Labarriere, Nathalie² (AUTHOR), Allory, Yves⁴ (AUTHOR), Larbouret, Christel¹ (AUTHOR), Gros, Laurent¹ (AUTHOR), Tosi, Diego¹ (AUTHOR), Solit, David B.⁵ (AUTHOR), Pourquier, Philippe¹ (AUTHOR), Houédé, Nadine¹ (AUTHOR), Gongora, Celine¹ (AUTHOR) celine.gongora@inserm.fr
Source:	Clinical & Translational Medicine. Sep2024, Vol. 14 Issue 9, p1-7. 7p.
Database:	Academic Search Ultimate
Full text is not displayed to guests. Login for full access.

Be the first to leave a comment!